Renaissance Technologies LLC Raises Holdings in DocGo Inc. (NASDAQ:DCGO)

Renaissance Technologies LLC boosted its position in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 583.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 350,600 shares of the company's stock after acquiring an additional 299,300 shares during the period. Renaissance Technologies LLC owned 0.34% of DocGo worth $1,487,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Barclays PLC lifted its holdings in shares of DocGo by 279.7% during the 3rd quarter. Barclays PLC now owns 134,923 shares of the company's stock valued at $447,000 after purchasing an additional 99,387 shares during the last quarter. Geode Capital Management LLC increased its position in DocGo by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,252,516 shares of the company's stock valued at $7,480,000 after buying an additional 39,016 shares in the last quarter. Franklin Resources Inc. raised its stake in DocGo by 11.6% in the third quarter. Franklin Resources Inc. now owns 1,199,086 shares of the company's stock valued at $3,933,000 after buying an additional 124,348 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in DocGo by 151.1% in the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company's stock worth $365,000 after acquiring an additional 66,097 shares in the last quarter. Finally, Harbor Capital Advisors Inc. boosted its holdings in DocGo by 37.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock worth $5,647,000 after acquiring an additional 363,391 shares in the last quarter. 56.44% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on DCGO shares. Needham & Company LLC reaffirmed a "buy" rating and issued a $4.00 price objective on shares of DocGo in a research report on Tuesday, April 8th. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a "buy" rating to a "hold" rating and decreased their price target for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, Stifel Nicolaus cut their target price on DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $4.89.

DocGo Price Performance

DCGO traded down $0.03 during trading on Thursday, reaching $2.20. 1,017,909 shares of the company's stock were exchanged, compared to its average volume of 744,625. DocGo Inc. has a 1 year low of $2.02 and a 1 year high of $5.68. The company's fifty day simple moving average is $2.72 and its 200-day simple moving average is $3.74. The stock has a market capitalization of $224.36 million, a P/E ratio of 7.86, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.